# Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

> **NCT02634788** · PHASE3 · COMPLETED · sponsor: **INSYS Therapeutics Inc** · enrollment: 322 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Buprenorphine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02634788
- **Lead sponsor:** INSYS Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-29
- **Primary completion:** 2016-06-24
- **Final completion:** 2016-06-24
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2017-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02634788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02634788, "Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02634788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*